Laboratory Data Analysis of Hemorrhagic Fever With Renal Syndrome Patients to Predict Disease Severity and Patient Prognosis
Journal of Clinical Laboratory Analysis · 2025
DOI: 10.1002/jcla.70126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Laboratory Analysis, 2025. Verfasst von Hong Shi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Baoji Central Hospital, Baoji, Shaanxi, China. Hauptthemen laut MEDLINE: Hemorrhagic Fever with Renal Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Basic Research Program of Shaanxi Province, University at Buffalo, State University of New York.
Abstract (Originalsprache)
Background
Hemorrhagic fever with renal syndrome ( HFRS ) is an endemic disease occurring in various parts of the world. Prompt access to care with proper treatment is essential for preventing patients from developing renal failure and unfavorite outcomes. This study aimed to elucidate laboratory parameters associated with HFRS severity and prognosis to predict disease course and initiate prompt clinical management.
Methods
Retrospective analysis of laboratory data was performed on HFRS patients from December 2016 to January 2022 in Baoji City of Shaanxi Province in China using different statistical methods.
Results
The WBC and neutrophils in peripheral blood, RBC in urine sediments, blood, protein, and glucose in urine, PT / INR , aPTT , TT , AST , ALT , AST / ALT , MAO , AD , urea, creatinine, cystatin C, CK ‐ MB , LDH , α‐ HBDH , mAST , triglycerides, glucose, amylase, ferritin, and PCT in serum increased in HFRS patients along with disease severity, while the lymphocytes, monocytes, platelets, plateletcrit, fibrinogen, serum total protein, albumin, HDL ‐c, magnesium, complement C3 and C4 , IgG , triiodothyronine, thyroxine, and free triiodothyronine were reduced. Results also indicated that in uncured HFRS patients, the NEUT %, CRP , cast, PT / INR , aPTT , D‐dimer, AST / ALT , CK ‐ MB , LDH , α‐ HBDH , m‐ AST , ferritin, and PCT were significantly higher than in cured patients, while platelets, C3 , and C4 in uncured patients were significantly lower than in cured patients. The NEUT %, CRP , AST / ALT , and LDH were associated with patients' prognosis.
Conclusions
Laboratory data are helpful in predicting HFRS patients' progress, severity, and prognosis, thus, these parameters are useful in guiding prompt clinical management of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Baoji Central Hospital, Baoji, Shaanxi, China.
- Department of Infectious Diseases, Baoji Central Hospital, Baoji, Shaanxi, China.
- Department of Laboratory Medicine, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China.
ORCID-Profile: Yaoni Li
Förderung
- Natural Science Basic Research Program of Shaanxi Province
- University at Buffalo
- State University of New York
Zitieren
APA
Shi, H., Du, F., Wang, T., Gu, Z., Ruan, T., Zhao, Q., Xu, R., Wang, Y., Luo, L., Wang, S., Jiang, L., & Li, Y. (2025). Laboratory Data Analysis of Hemorrhagic Fever With Renal Syndrome Patients to Predict Disease Severity and Patient Prognosis. Journal of Clinical Laboratory Analysis. https://doi.org/10.1002/jcla.70126
Vancouver
Shi H, Du F, Wang T, Gu Z, Ruan T, Zhao Q, et al. Laboratory Data Analysis of Hemorrhagic Fever With Renal Syndrome Patients to Predict Disease Severity and Patient Prognosis. Journal of Clinical Laboratory Analysis. 2025. doi:10.1002/jcla.70126
BibTeX
@article{Shi2025,
author = {Shi, Hong and Du, Feng and Wang, Ting and Gu, Zhendong and Ruan, Ting and Zhao, Qiujian and Xu, Rui and Wang, Yi and Luo, Langxi and Wang, Shaohua and Jiang, Liejun and Li, Yaoni},
title = {Laboratory Data Analysis of Hemorrhagic Fever With Renal Syndrome Patients to Predict Disease Severity and Patient Prognosis},
journal = {Journal of Clinical Laboratory Analysis},
year = {2025},
doi = {10.1002/jcla.70126}
}
EUVIMED